Results 101 to 110 of about 21,592 (229)

Effect of Weekly Alendronate on Knee Symptoms in Patients with Osteoporosis and Knee Osteoarthritis Coexistence - Original Investigation

open access: yes, 2010
Aim: The aim of this study was to examine the effect of alendronate 70 mg weekly on knee symptoms in elderly women with osteoporosis and knee OA coexistence.
Murat Toprak   +3 more
core  

The effects of alendronate on muscle volume and osteoclasts.

open access: yes, 2014
(A) There was no significant effect of alendronate on muscle volume at P28. Muscle volume was significantly reduced in the Botox group compared to the Saline and Normal groups. (B) Alendronate dose and group (Botox vs. Saline vs.
Stavros Thomopoulos (299362)   +7 more
core   +1 more source

An Injectable Metal‐Drug Supramolecular Condensate Enables Radiosensitization and Systemic Antitumor Immunity for Post‐Surgical Osteosarcoma Therapy

open access: yesAdvanced Science, Volume 13, Issue 64, 16 November 2026.
This work designed an injectable metal‐drug supramolecular condensate formed from hafnium ions and alendronate (Hf‐ALN) and loaded with the COX‐2 inhibitor celecoxib (CXB) for synergistic radioimmunotherapy of postoperative osteosarcoma. Mechanistically, upon X‐ray irradiation, Hf enhances radiation energy deposition, ROS generation, and DNA damage ...
Tianhua Xiao   +12 more
wiley   +1 more source

The Effect of Alendronate and Intranasal Calcitonin Treatments on Bone Mineral Density in Men with Idiopathic Osteoporosis

open access: yes, 2003
The aim of this study was to compare the effect of alendronate and calcitonin treatments on bone mineral density (BMD) in men with idiopathic osteoporosis.
Ayşe Aydemir   +2 more
core  

Resveratrol Modulates Bone Metabolism Through SIRT1‐Mediated NF‐κB Inhibition: Molecular Mechanisms and Therapeutic Implications

open access: yesCell Biochemistry and Function, Volume 44, Issue 11, November 2026.
ABSTRACT Osteoporosis and associated skeletal pathologies impose a staggering global health burden, disproportionately impacting elderly populations and postmenopausal women. At the root of excessive bone resorption and stalled osteogenesis lie persistent oxidative stress and chronic inflammation.
Seyyed Hossein Khatami   +11 more
wiley   +1 more source

Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation

open access: yes, 2013
Kazuhiro Imai Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan Abstract: Osteoporosis is a skeletal disorder characterized by loss of bone mass, decreased bone strength, and an increased risk of ...
Imai K
core  

REVIEW OF BASIC CLINICAL TRIALS OF ALENDRONATE [PDF]

open access: yes, 2010
Development Bisphosphonates are a major class of drugs used to treat osteoporosis (OP) and other diseases characterized by increased bone resorption. The literature contains indisputable evidence for the efficacy of alendronate in the registered oral ...
E G Zotkin
core   +1 more source

Bioactive Glass Dressings for Infected Wounds: A Systematic Review

open access: yesInternational Wound Journal, Volume 23, Issue 11, November 2026.
ABSTRACT Wounds pose a clinical challenge due to their susceptibility to infection and complex healing environments. Wound infection with multi‐drug‐resistant bacteria increases the mortality and morbidity, with new strategies needed to treat them. Bioactive glasses are biodegradable glasses that interact with biological systems by releasing ions such ...
Nandesh C. Patel   +4 more
wiley   +1 more source

ALENDRONATE-INDUCED RESPIRATORY DISTRESS [PDF]

open access: yes, 2020
Respiratory distress is a rare adverse effect of alendronate that is typically associated with severe dyspnoea and wheezing and typically requires hospitalization.
M, PRAVALIKA, V, SRIVANI, PAMU, SAGAR
core   +1 more source

Artificial Intelligence‐Driven Precision Bisphosphonate Therapy in Osteoporosis: Mechanisms, Clinical Applications, Risks, and Future Directions

open access: yesOrthopaedic Surgery, Volume 18, Issue 11, Page 2309-2319, November 2026.
This comprehensive review integrates 17 benchmark studies to illustrate the transition of osteoporosis management toward precision medicine. The schematic highlights three key clinical applications: AI‐driven opportunistic screening from routine CTs, precision pharmacotherapy selection, and the predictive prevention of adverse events like MRONJ ...
Xiang Yao   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy